Old Web
English
Sign In
Acemap
>
authorDetail
>
Patrick Vollmar
Patrick Vollmar
Novartis
Physical therapy
Interim
Fingolimod
Medicine
Economic data
2
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Interim Results of the PANGAEA and PEARL Studies, Comparing Treatment Satisfaction and Pharmaco-Economic Data of Fingolimod (Gilenya®) and First-Line Therapies in Multiple Sclerosis Patients in Germany (P03.220)
2013
Neurology
Tjalf Ziemssen
Patrick Vollmar
Matthias Meergans
Ferenc Tracik
Maria Diaz-Lorente
Katja Neidhardt
Tom van Lokven
Show All
Source
Cite
Save
Citations (1)
18-Month Interim Results of a Registry Study To Establish Long-Term Safety and Pharmaco-Economic Data on Fingolimod (Gilenya®) in Multiple Sclerosis Patients in Germany (PANGAEA) (P01.185)
2013
Neurology
Tjalf Ziemssen
Maria Diaz-Lorente
Patrick Vollmar
Matthias Meergans
Ferenc Tracik
Raimar Kempcke
Tom van Lokven
Show All
Source
Cite
Save
Citations (2)
1